title: [Questions to the Drug Committee about administration of Lyrica].
authors.forename: Flemming W
authors.initials: FW
authors.lastname: Bach
authors.forename: Troels Staehelin
authors.initials: TS
authors.lastname: Jensen
authors.forename: Niels-Henrik
authors.initials: NH
authors.lastname: Jensen
authors.forename: Ryan W
authors.initials: RW
authors.lastname: Hansen
authors.forename: Birte Saxtoft
authors.initials: BS
authors.lastname: Hedal
authors.forename: Anne G
authors.initials: AG
authors.lastname: Korsgaard
authors.forename: Torsten
authors.initials: T
authors.lastname: Jonsson
authors.forename: Sandal
authors.initials: S
authors.lastname: Jeppesen
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage* / Q000627:therapeutic use; D003718:Denmark; D004335:Drug and Narcotic Control; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid